Oxford Asset Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$696K Buy
+27,812
New +$658K 0.3% 94
2025
Q4
Sell
-36,359
Closed -$621K 770
2025
Q3
$621K Buy
+36,359
New +$520K 0.21% 146
2020
Q1
Sell
-29,311
Closed -$1.33M 1355
2019
Q4
$1.33M Sell
29,311
-39,826
-58% -$1.45M 0.04% 675
2019
Q3
$1.72M Sell
69,137
-47,616
-41% -$1.19M 0.04% 634
2019
Q2
$2.57M Buy
+116,753
New +$2.14M 0.06% 532
2019
Q1
Sell
-28,402
Closed -$417K 2035
2018
Q4
$417K Buy
+28,402
New +$373K 0.01% 1267
2017
Q3
Sell
-18,467
Closed -$154K 1739
2017
Q2
$154K Buy
+18,467
New +$207K ﹤0.01% 1388

Other funds holding ZYME

Oxford Asset Management's ZYME Position: Q1 2026 in Review

Oxford Asset Management opened a new position in Zymeworks (ZYME) in Q1 2026: 27,812 shares worth $696K. The stake represents 0.3% of the portfolio and ranks #94 among its holdings. This is a return to the name: Oxford Asset Management previously reported a position in ZYME as recently as Q3 2025.

Oxford Asset Management first reported a position in ZYME in Q2 2017 and has held it in 7 quarters since. The position peaked at $2.57M in Q2 2019. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Oxford Asset Management held 27,812 shares of Zymeworks worth $696K as of Q1 2026.
  • Zymeworks was a new Oxford Asset Management position in Q1 2026.
  • Zymeworks made up 0.3% of Oxford Asset Management's portfolio in Q1 2026, its #94 holding.
  • Oxford Asset Management first reported a position in Zymeworks in Q2 2017 and has held it in 7 quarters since.
  • Oxford Asset Management's Zymeworks position peaked at $2.57M in Q2 2019.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.